Chemoinformaics analysis of DEHYDROANHYDROLYCORINE
| Molecular Weight | 249.269 | nRot | 0 |
| Heavy Atom Molecular Weight | 238.181 | nRig | 23 |
| Exact Molecular Weight | 249.079 | nRing | 5 |
| Solubility: LogS | -6.405 | nHRing | 3 |
| Solubility: LogP | 4.047 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 16 |
| nHA | 3 | APOL | 36.7587 |
| nHD | 0 | BPOL | 16.2173 |
| QED | 0.477 |
| Synth | 2.623 |
| Natural Product Likeliness | 0.24 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.027 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.849 |
| MDCK | 0.0000271 |
| BBB | 0.781 |
| PPB | 0.972252 |
| VDSS | 1.156 |
| FU | 0.0196082 |
| CYP1A2-inh | 0.991 |
| CYP1A2-sub | 0.161 |
| CYP2c19-inh | 0.973 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.756 |
| CYP2c9-sub | 0.883 |
| CYP2d6-inh | 0.971 |
| CYP2d6-sub | 0.921 |
| CYP3a4-inh | 0.952 |
| CYP3a4-sub | 0.166 |
| CL | 16.322 |
| T12 | 0.139 |
| hERG | 0.058 |
| Ames | 0.888 |
| ROA | 0.103 |
| SkinSen | 0.113 |
| Carcinogencity | 0.955 |
| EI | 0.314 |
| Respiratory | 0.307 |
| NR-Aromatase | 0.486 |
| Antiviral | Yes |
| Prediction | 0.625955 |